Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1938 1
1939 5
1940 1
1941 1
1942 1
1946 2
1947 3
1948 5
1949 2
1950 12
1951 13
1952 35
1953 21
1954 9
1955 12
1956 9
1957 22
1958 17
1959 21
1960 11
1961 13
1962 28
1963 48
1964 34
1965 42
1966 43
1967 40
1968 32
1969 40
1970 41
1971 40
1972 55
1973 60
1974 64
1975 62
1976 94
1977 84
1978 89
1979 125
1980 140
1981 169
1982 222
1983 209
1984 259
1985 294
1986 311
1987 384
1988 394
1989 428
1990 523
1991 574
1992 633
1993 752
1994 826
1995 980
1996 1115
1997 1330
1998 1483
1999 1834
2000 2162
2001 2500
2002 2988
2003 3491
2004 4170
2005 5047
2006 5805
2007 6345
2008 7425
2009 8177
2010 9261
2011 10533
2012 12075
2013 13228
2014 14832
2015 15969
2016 16979
2017 18127
2018 20150
2019 22902
2020 26510
2021 30136
2022 13181
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

256,396 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Shiue-Der
Page 1
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC.
Hänscheid H, Hartrampf PE, Schirbel A, Buck AK, Lapa C. Hänscheid H, et al. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2566-2572. doi: 10.1007/s00259-020-05177-z. Epub 2021 Jan 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33452632 Free PMC article.
It was tested in selected patients whether the substance is superior to [(177)Lu]Lu-DOTA-TOC. METHODS: Activity kinetics in organs and tumours after [(177)Lu]Lu-DOTA-EB-TATE and [(177)Lu]Lu-DOTA-TOC were compared intraindividually in five …
It was tested in selected patients whether the substance is superior to [(177)Lu]Lu-DOTA-TOC. METHODS: Activity kinetics in or …
MiR-20a regulates fibroblast-like synoviocyte proliferation and apoptosis in rheumatoid arthritis.
Wei XJ, Li XW, Lu JL, Long ZX, Liang JQ, Wei SB, Lu CX, Lu WZ. Wei XJ, et al. Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7578. doi: 10.26355/eurrev_202007_22253. Eur Rev Med Pharmacol Sci. 2020. PMID: 32744683
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-20a regulates fibroblast-like synoviocyte proliferation and apoptosis in rheumatoid arthritis, by X.-J. Wei, X. …
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originali …
First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2.
Ballal S, Yadav MP, Moon ES, Kramer VS, Roesch F, Kumari S, Bal C. Ballal S, et al. Pharmaceuticals (Basel). 2021 Nov 24;14(12):1212. doi: 10.3390/ph14121212. Pharmaceuticals (Basel). 2021. PMID: 34959613 Free PMC article.
The FAPi agents, [(177)Lu]Lu-DOTA.SA.FAPi and [(177)Lu]Lu-DOTAGA.(SA.FAPi)(2), were administered in two different groups of patients. ...The first clinical dosimetry study demonstrated significantly higher tumor absorbed doses with [(177)Lu]L
The FAPi agents, [(177)Lu]Lu-DOTA.SA.FAPi and [(177)Lu]Lu-DOTAGA.(SA.FAPi)(2), were administered in two differen …
Lutetium Lu 177 Dotatate.
[No authors listed] [No authors listed] 2020 Aug 17. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2020 Aug 17. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000023 Free Books & Documents. Review.
Lutetium Lu 177 dotatate is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors. No information is available on the use of lutetium Lu 177 dotatate during breastfeeding. The ma …
Lutetium Lu 177 dotatate is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor-positive gastroen …
Modelling of the 177mLu/177Lu radionuclide generator.
Bhardwaj R, Wolterbeek HT, Denkova AG, Serra-Crespo P. Bhardwaj R, et al. Appl Radiat Isot. 2020 Dec;166:109261. doi: 10.1016/j.apradiso.2020.109261. Epub 2020 Jul 10. Appl Radiat Isot. 2020. PMID: 32961525 Free article.
In order to determine the potential of (177m)Lu/(177)Lu radionuclide generator in (177)Lu production it is important to establish the technical needs that can lead to a clinically acceptable (177)Lu product quality. ...The dissociation rate constants l …
In order to determine the potential of (177m)Lu/(177)Lu radionuclide generator in (177)Lu production it is important to …
Inside Wuhan's lockdown.
Lu D. Lu D. New Sci. 2020 Feb 8;245(3268):7. doi: 10.1016/S0262-4079(20)30234-7. Epub 2020 Feb 7. New Sci. 2020. PMID: 32287788 Free PMC article.
Hubei residents are trying to stay positive as hospitals attempt to treat thousands infected by the new coronavirus, reports Donna Lu....
Hubei residents are trying to stay positive as hospitals attempt to treat thousands infected by the new coronavirus, reports Donna Lu
177Lu-labeled micro liposomes as a potential radiosynoviorthesis therapeutic agent.
Cvjetinović Đ, Janković D, Milanović Z, Mirković M, Petrović J, Prijović Ž, Poghosyan E, Vranješ-Đurić S. Cvjetinović Đ, et al. Int J Pharm. 2021 Oct 25;608:121106. doi: 10.1016/j.ijpharm.2021.121106. Epub 2021 Sep 17. Int J Pharm. 2021. PMID: 34537268
Micro-sized multivesicular liposomes were prepared, radiolabeled with (177)Lu, and tested in vitro and in vivo to evaluate the potential of (177)Lu-labeled micro liposomes in radiosynoviorthesis (RSO) therapy. ...Leakage of free (177)Lu or (177)Lu-lipo …
Micro-sized multivesicular liposomes were prepared, radiolabeled with (177)Lu, and tested in vitro and in vivo to evaluate the potent …
Comparison of biological properties of [177 Lu]Lu-ProBOMB1 and [177 Lu]Lu-NeoBOMB1 for GRPR targeting.
Rousseau E, Lau J, Zhang Z, Zhang C, Kwon D, Uribe CF, Kuo HT, Zeisler J, Bratanovic I, Lin KS, Bénard F. Rousseau E, et al. J Labelled Comp Radiopharm. 2020 Feb;63(2):56-64. doi: 10.1002/jlcr.3815. Epub 2020 Jan 11. J Labelled Comp Radiopharm. 2020. PMID: 31715025
Lu-NeoBOMB1 had better binding affinity for GRPR than Lu-ProBOMB1 (K(i) values: 2.26 0.24 and 30.2 3.23nM). [(177) Lu]Lu-ProBOMB1 was obtained in 53.7 5.4% decay-corrected radiochemical yield with 444.2 193.2 GBq/mumol molar activity and >95% radioc
Lu-NeoBOMB1 had better binding affinity for GRPR than Lu-ProBOMB1 (K(i) values: 2.26 0.24 and 30.2 3.23nM). [(177) Lu]
Children's immunity at risk.
Lu D. Lu D. New Sci. 2021 May 1;250(3332):8-9. doi: 10.1016/S0262-4079(21)00716-8. Epub 2021 Apr 30. New Sci. 2021. PMID: 33967369 Free PMC article.
Young children who have spent much of their lives under coronavirus restrictions now seem more vulnerable to a number of other conditions, finds Donna Lu....
Young children who have spent much of their lives under coronavirus restrictions now seem more vulnerable to a number of other conditions, f …
Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [177Lu]Lu-OPS201 Compared to the Agonist [177Lu]Lu-DOTA-TATE.
Mansi R, Plas P, Vauquelin G, Fani M. Mansi R, et al. Pharmaceuticals (Basel). 2021 Dec 4;14(12):1265. doi: 10.3390/ph14121265. Pharmaceuticals (Basel). 2021. PMID: 34959665 Free PMC article.
While [(177)Lu]Lu-OPS201 and [(177)Lu]Lu-DOTA-TATE exhibited comparable affinity (K(D), 0.15 0.003 and 0.08 0.02 nM, respectively), [(177)Lu]Lu-OPS201 recognized four times more binding sites than [(177)Lu]Lu-DOTA-TATE. ...T …
While [(177)Lu]Lu-OPS201 and [(177)Lu]Lu-DOTA-TATE exhibited comparable affinity (K(D), 0.15 0.003 and 0.08 0.02 …
256,396 results
You have reached the last available page of results. Please see the User Guide for more information.